TGFB1 and neoplasm: As tumors progress and lose the capacity to respond to TGFβ-mediated growth arrest effect on tumor epithelial cells, TGFβ promotes tumor progression via numerous pathways12, including functioning as a potent immune suppressor13, thus presenting itself as a potential therapeutic target in locally advanced SCCs.